US: +1 630 333 9501 |
UK: +44 208 123 1770 |
Global Human Vaccines Market 2011-2015
|
SKU: IRTNTR1259
Pages:
42 DescriptionDescription:
TechNavio's analysts forecast the Global Human Vaccines market to reach US$57.6 billion by 2015. One of the key factors contributing to this market growth is the increase in demand for vaccination against communicable diseases. The Global Human Vaccines market has also been witnessing the increase in awareness programs worldwide. However, emergence of vaccine-resistant viruses could pose a challenge to the growth of this market. TechNavio's report, the Global Human Vaccines Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include GlaxoSmithKline plc, Merck and Co. Inc., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report:: ALK Abello A/S, AstraZeneca plc, Bavarian Nordic A/S, Baxter International Inc., CSL Ltd., MedImmune Inc., Novartis AG, Shanta Biotechnics Ltd., Sinovac Biotech Ltd., and Vaxin Inc. Key questions answered in this report: You can request one free hour of analyst time when you purchase this report. Details provided within the report. TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market. Table of ContentsTable of Contents:
01. Executive Summary
02. Introduction 03. Market Coverage Market Overview Key Products 04. Market Landscape Market Size Market Segmentation by Vaccine Application Market Segmentation by Consumers Market Size of Global Pediatric Vaccines Market Five Forces Analysis 05. Geographical Segmentation 06. Key Leading Countries USA Germany France UK 07. Rate of Incidence and Prevalence 08. Vendor Landscape 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact Drivers and their Impact: End-users Drivers and their Impact: Geography 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 15.1 GlaxoSmithKline plc Business Overview SWOT Analysis 15.2 Sanofi S.A. Business Overview SWOT Analysis 32 15.3 Pfizer Inc. Business Overview SWOT Analysis 15.4 Merck and Co. Inc. Business Overview SWOT Analysis 16. Other Reports in this Series List of Exhibits: Exhibit 1: Global Human Vaccines Market 2011-2015 (US$ billion) Exhibit 2: Global Human Vaccines Market Segmentation Exhibit 3: Global Human Vaccines Market Segmentation by Application 2011 Exhibit 4: Global Human Vaccines Market Segmentation by Consumers 2011 Exhibit 5: Global Pediatric Vaccines Market 2011-2015 (US$ billion) Exhibit 6: Global Human Vaccines Market by Geographical Segmentation 2011 Exhibit 7: Hepatitis C Infection by Source in 2011 Exhibit 8: Global Human Vaccines Market by Vendor Segmentation 2011 |
Published June 13, 2012
Single User License: Allows one specific user access to the report Three User License: Allows up to three employees within your organization access to the report Five User License: Allows up to five employees within your organization access to the report Enterprise License: Allows all employees within your organization access to the report |